Brief: Control Bionics Anticipates U.S. Revenue For 1H Will Exceed By More Than 15%
17/12/2024 01:11
Dec 17 (Reuters) - Control Bionics Ltd CBL.AX :
* ANTICIPATE US REVENUE FOR 1H FY25 WILL EXCEED BY MORE THAN
15%
* REVENUE IN H2 OF CALENDAR 2024 EXPECTED TO BE ALMOST 30%
HIGHER
THAN FIRST 6 MONTHS OF CY2024
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device